These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

431 related items for PubMed ID: 16029342

  • 1. Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus: results of a retrospective study in 43 patients.
    Wenzel J, Brähler S, Bauer R, Bieber T, Tüting T.
    Br J Dermatol; 2005 Jul; 153(1):157-62. PubMed ID: 16029342
    [Abstract] [Full Text] [Related]

  • 2. Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus.
    Carneiro JR, Sato EI.
    J Rheumatol; 1999 Jun; 26(6):1275-9. PubMed ID: 10381042
    [Abstract] [Full Text] [Related]

  • 3. An open-label, dose-ranging study of methotrexate for moderate-to-severe adult atopic eczema.
    Weatherhead SC, Wahie S, Reynolds NJ, Meggitt SJ.
    Br J Dermatol; 2007 Feb; 156(2):346-51. PubMed ID: 17223876
    [Abstract] [Full Text] [Related]

  • 4. Mycophenolate sodium for subacute cutaneous lupus erythematosus resistant to standard therapy.
    Kreuter A, Tomi NS, Weiner SM, Huger M, Altmeyer P, Gambichler T.
    Br J Dermatol; 2007 Jun; 156(6):1321-7. PubMed ID: 17408395
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of topical tacrolimus 0.3% in clobetasol propionate 0.05% ointment in therapy-resistant cutaneous lupus erythematosus: a cohort study.
    Madan V, August PJ, Chalmers RJ.
    Clin Exp Dermatol; 2010 Jan; 35(1):27-30. PubMed ID: 19549244
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and tolerability of methotrexate in antimalarial resistant lupus arthritis.
    Rahman P, Humphrey-Murto S, Gladman DD, Urowitz MB.
    J Rheumatol; 1998 Feb; 25(2):243-6. PubMed ID: 9489814
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of methotrexate in articular and cutaneous manifestations of systemic lupus erythematosus.
    Islam MN, Hossain M, Haq SA, Alam MN, Ten Klooster PM, Rasker JJ.
    Int J Rheum Dis; 2012 Feb; 15(1):62-8. PubMed ID: 22324948
    [Abstract] [Full Text] [Related]

  • 8. Low-dose methotrexate treatment for moderate-to-severe atopic dermatitis in adults.
    Lyakhovitsky A, Barzilai A, Heyman R, Baum S, Amichai B, Solomon M, Shpiro D, Trau H.
    J Eur Acad Dermatol Venereol; 2010 Jan; 24(1):43-9. PubMed ID: 19552716
    [Abstract] [Full Text] [Related]

  • 9. Long-term methotrexate for Crohn's disease: safety and efficacy in clinical practice.
    Domènech E, Mañosa M, Navarro M, Masnou H, Garcia-Planella E, Zabana Y, Cabré E, Gassull MA.
    J Clin Gastroenterol; 2008 Apr; 42(4):395-9. PubMed ID: 18277899
    [Abstract] [Full Text] [Related]

  • 10. Topical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: a possible alternative.
    Lampropoulos CE, Sangle S, Harrison P, Hughes GR, D'Cruz DP.
    Rheumatology (Oxford); 2004 Nov; 43(11):1383-5. PubMed ID: 15266063
    [Abstract] [Full Text] [Related]

  • 11. Thalidomide for the treatment of resistant cutaneous lupus: efficacy and safety of different therapeutic regimens.
    Cuadrado MJ, Karim Y, Sanna G, Smith E, Khamashta MA, Hughes GR.
    Am J Med; 2005 Mar; 118(3):246-50. PubMed ID: 15745722
    [Abstract] [Full Text] [Related]

  • 12. Methotrexate treatment for sarcoid-associated panuveitis.
    Dev S, McCallum RM, Jaffe GJ.
    Ophthalmology; 1999 Jan; 106(1):111-8. PubMed ID: 9917790
    [Abstract] [Full Text] [Related]

  • 13. Folic acid supplementation during treatment of psoriasis with methotrexate: a randomized, double-blind, placebo-controlled trial.
    Salim A, Tan E, Ilchyshyn A, Berth-Jones J.
    Br J Dermatol; 2006 Jun; 154(6):1169-74. PubMed ID: 16704650
    [Abstract] [Full Text] [Related]

  • 14. Thalidomide in the treatment of refractory cutaneous lupus erythematosus: prognostic factors of clinical outcome.
    Cortés-Hernández J, Torres-Salido M, Castro-Marrero J, Vilardell-Tarres M, Ordi-Ros J.
    Br J Dermatol; 2012 Mar; 166(3):616-23. PubMed ID: 21999437
    [Abstract] [Full Text] [Related]

  • 15. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.
    Hroch M, Chladek J, Simkova M, Vaneckova J, Grim J, Martinkova J.
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504
    [Abstract] [Full Text] [Related]

  • 16. Corticosteroid sparing effect of low dose methotrexate treatment in adult Still's disease.
    Fautrel B, Borget C, Rozenberg S, Meyer O, Le Loët X, Masson C, Koeger AC, Kahn MF, Bourgeois P.
    J Rheumatol; 1999 Feb; 26(2):373-8. PubMed ID: 9972972
    [Abstract] [Full Text] [Related]

  • 17. Methotrexate is an effective and safe adjuvant therapy for pemphigus vulgaris.
    Baum S, Greenberger S, Samuelov L, Solomon M, Lyakhovitsky A, Trau H, Barzilai A.
    Eur J Dermatol; 2012 Feb; 22(1):83-7. PubMed ID: 22266247
    [Abstract] [Full Text] [Related]

  • 18. Combined treatment with low-dose methotrexate and initial short-term superpotent topical steroids in bullous pemphigoid: an open, multicentre, retrospective study.
    Du-Thanh A, Merlet S, Maillard H, Bernard P, Joly P, Estève E, Richard MA, Pauwels C, Ingen-Housz-Oro S, Guillot B, Dereure O.
    Br J Dermatol; 2011 Dec; 165(6):1337-43. PubMed ID: 21777222
    [Abstract] [Full Text] [Related]

  • 19. Methotrexate therapy in refractory pediatric onset systemic lupus erythematosus.
    Ravelli A, Ballardini G, Viola S, Villa I, Ruperto N, Martini A.
    J Rheumatol; 1998 Mar; 25(3):572-5. PubMed ID: 9517783
    [Abstract] [Full Text] [Related]

  • 20. Methotrexate for the treatment of adult atopic dermatitis.
    Goujon C, Bérard F, Dahel K, Guillot I, Hennino A, Nosbaum A, Saad N, Nicolas JF.
    Eur J Dermatol; 2006 Mar; 16(2):155-8. PubMed ID: 16581567
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.